In an effort to encourage more blood donations, the Food and Drug Administration today said it is revisiting and updating several existing policies to help ensure an adequate-but-safe national blood supply.

To account for COVID-19, the agency is providing notice of alternatives to certain blood donor eligibility requirements for the duration of the pandemic. Among other changes, the guidance allows blood centers to reduce donation deferral periods for certain categories of blood donors from 12 months to three. FDA said it will provide notification when the alternative procedures are no longer in effect.

FDA also issued the following:

According to the agency, these recommendations are expected to remain in place after the COVID-19 pandemic ends, with any appropriate changes based on comments FDA receives.

Related News Articles

Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…